Scout | NOT-CA-24-016: Notice of Special Interest (NOSI): Exploratory Cancer Immunology Projects and Technologies (ExCITe)

grant

Notice of Special Interest (NOSI): Exploratory Cancer Immunology Projects and Technologies (ExCITe)

Summary

The National Cancer Institute (NCI) is inviting applications for R21 grants aimed at high-risk, high-reward research in cancer immunology. The goal is to explore new ideas or technologies that could enhance our understanding of immune responses, tumor-immune interactions, and immune networks related to cancer. These projects should be innovative and different from typical R01 projects, with th…

The National Cancer Institute (NCI) is encouraging R21 applications for innovative high-risk/high-reward research projects in cancer immunology. The focus is on novel hypotheses or technologies to advance understanding of cancer immunology, including immune responses, tumor-immune ecosystems, an…

Source

Agency: Department of Health and Human Services

Sub-agency: National Institutes of Health

Eligibility

Higher Education Institutions — Public/State-controlled Institutions of Higher Education

Higher Education Institutions — Private Institutions of Higher Education

Nonprofit Organizations with 501(c)(3) status (other than Institutions of Higher Education)

Nonprofit Organizations without 501(c)(3) status (other than Institutions of Higher Education)

For-Profit Organizations (other than Small Businesses)

Small Businesses

State Governments

County Governments

City or Township Governments

Special District Governments

Independent School Districts

Public Housing Authorities/Indian Housing Authorities

Native American Tribal Governments (Federally recognized)

Native American Tribal Governments (Other than Federally recognized)

Native American Tribal Organizations (other than Federally recognized Tribal Governments)

U.S. Territories or Possessions

Eligible Agencies of the Federal Government

Regional Organizations

Faith-based Organizations

Non-domestic (non-U.S.) components of U.S. Organizations — as allowed by the parent NOFOs

Community-based Organizations

Foreign/Non-domestic Entities (Foreign Institutions) — as allowed by the parent NOFOs (PA-20-195, PA-20-196)

Foreign components of U.S. projects — as allowed by the parent NOFOs

This is a Notice of Special Interest (NOSI) from NCI (NOT-CA-24-016). Applications must be submitted under one of the specified parent R21 NOFOs and follow all SF424 (R&R) and NOFO instructions. Key conditions: 1) Submit under PA-20-195 (NIH Parent R21, Clinical Trial Not Allowed) or PA-20-1…

Notice of Special Interest (NOSI): Exploratory Cancer Immunology Projects and Technologies (ExCITe)

Source

Eligibility

Dates

Supporting links

Similar opportunities